10-QCCCCCIK 0001662579
C4 Therapeutics, Inc.
Quarterly report (10-Q) filed .
Unaudited quarterly financial report filed by U.S. public companies for the first three fiscal quarters.
New to the 10-Q? What it is and how to read oneFiling facts
- Accession number
- 0001628280-25-049854
- Filer
- C4 Therapeutics, Inc.
- Ticker
- CCCC
- CIK
- 0001662579
- Form type
- 10-Q
- Form description
- Quarterly report
- Filed at
- November 6, 2025
- Period of report
- September 30, 2025
- Industry
- SIC 2836Biological Products
- Filing size
- 6.4 MB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
More filings from C4 Therapeutics, Inc.
See all 42 filings from C4 Therapeutics, Inc. →Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1662579/000162828025049854/0001628280-25-049854-index.htm ↗Filer's full EDGAR submission history
EDGAR · C4 Therapeutics, Inc. (0001662579) ↗SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.